Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Open in API
Filings indexed 1,398 across all filing types
Latest filing 2008-12-05 Declaration of Voting R…
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
Fresenius SE: Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is very short (1197 characters) and its primary purpose is to announce a specific regulatory metric: the 'Total Voting Rights' as of the end of December 2008, referencing Article 26a of the WpHG (German Securities Trading Act). This type of announcement, which reports on the total number of shares with voting rights, is a specific regulatory disclosure. It is not a full report (10-K, IR), an earnings release (ER), or a management change (MANG). It most closely aligns with a general regulatory announcement that doesn't fit the other specific categories like Director's Dealing (DIRS) or Major Shareholding Notification (MRQ). Given the options, 'Regulatory Filings' (RNS) serves as the best general category for mandatory, non-standardized regulatory disclosures that don't fit elsewhere, although it is related to voting rights, it is not the *results* of a vote (DVA). Since it is a mandatory disclosure about the capital structure/voting rights, RNS is the most appropriate fallback.
2008-12-05 English
Fresenius SE: Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is very short (1198 characters) and announces a specific numerical update regarding the 'Total Voting Rights' as of November 2008, referencing Article 26a of the WpHG (German Securities Trading Act). This type of announcement, which reports on the total number of shares with voting rights, is a specific regulatory disclosure. It is not a full report (10-K, IR), an earnings release (ER), or a management change (MANG). It most closely aligns with a regulatory notification concerning share structure or voting power. Since there is no specific code for 'Total Voting Rights Announcement', and it is a mandatory regulatory disclosure that doesn't fit the other specific categories (like DVA which is for *results* of a vote, not the total rights count), the most appropriate fallback category is Regulatory Filings (RNS).
2008-11-28 English
DGAP-DD: Fresenius SE english
Director's Dealing Classification · 100% confidence The document explicitly uses the header "Directors’ Dealings" and details a transaction made by a person in a managing body ("Sturm, Stephan, Position: Member of a managing body"). The content describes the purchase of Fresenius SE Ordinary Shares, which is the definition of insider trading disclosure required for directors. This directly maps to the 'Director's Dealing' category.
2008-11-17 English
DGAP-DD: Fresenius SE english
Director's Dealing Classification · 100% confidence The document explicitly uses the header "Directors’ Dealings" and details a transaction (Sale) made by a person in a managing body (Stephan Sturm) concerning the company's shares (Fresenius SE preference share). This directly matches the definition for Director's Dealing, which corresponds to the filing code DIRS.
2008-11-17 English
Q3 Report 2008
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Financial Report' for the Fresenius Group covering the first three quarters of 2008. It contains comprehensive financial statements (income statement, balance sheet, cash flow), segment reporting, and a detailed management report. It is not an announcement or a short summary, but the full interim report itself, fitting the definition of an Interim/Quarterly Report (IR). 9M 2008
2008-11-14 German
DGAP-DD: Fresenius SE english
Director's Dealing Classification · 100% confidence The document text explicitly contains the header "Directors’ Dealings" and details a transaction (Sale) by a person in a managing body (Stephan Sturm) involving company shares (Fresenius SE Preference Share). This directly matches the definition for Director's Dealing, which corresponds to the filing code DIRS.
2008-11-06 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.